These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 17571247)
1. Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy. Jung Y; Park J; Kim TY; Park JH; Jong HS; Im SA; Robertson KD; Bang YJ; Kim TY J Mol Med (Berl); 2007 Oct; 85(10):1137-48. PubMed ID: 17571247 [TBL] [Abstract][Full Text] [Related]
2. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation. Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630 [TBL] [Abstract][Full Text] [Related]
3. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP]. Meng CF; Dai DQ; Guo KJ Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988 [TBL] [Abstract][Full Text] [Related]
4. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells. Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of 5-Aza-2'-deoxycytidine against gastric cancer involves DNA damage in an ATM-P53 dependent signaling pathway and demethylation of P16(INK4A). Liu J; Xie YS; Wang FL; Zhang LJ; Zhang Y; Luo HS Biomed Pharmacother; 2013 Feb; 67(1):78-87. PubMed ID: 23201008 [TBL] [Abstract][Full Text] [Related]
6. De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine. Oka M; Meacham AM; Hamazaki T; Rodić N; Chang LJ; Terada N Oncogene; 2005 Apr; 24(19):3091-9. PubMed ID: 15735669 [TBL] [Abstract][Full Text] [Related]
7. 5-Aza-2'-deoxycytidine induces cytotoxicity in BGC-823 cells via DNA methyltransferase 1 and 3a independent of p53 status. Liu J; Zhang Y; Xie YS; Wang FL; Zhang LJ; Deng T; Luo HS Oncol Rep; 2012 Aug; 28(2):545-52. PubMed ID: 22664909 [TBL] [Abstract][Full Text] [Related]
8. Effect of inhibition of MEK pathway on 5-aza-deoxycytidine-suppressed pancreatic cancer cell proliferation. Wang X; Wang H; Jiang N; Lu W; Zhang XF; Fang JY Genet Mol Res; 2013 Nov; 12(4):5560-73. PubMed ID: 24301926 [TBL] [Abstract][Full Text] [Related]
9. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Yang X; Phillips DL; Ferguson AT; Nelson WG; Herman JG; Davidson NE Cancer Res; 2001 Oct; 61(19):7025-9. PubMed ID: 11585728 [TBL] [Abstract][Full Text] [Related]
10. 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1. Maslov AY; Lee M; Gundry M; Gravina S; Strogonova N; Tazearslan C; Bendebury A; Suh Y; Vijg J Oncogene; 2012 Dec; 31(50):5172-9. PubMed ID: 22349820 [TBL] [Abstract][Full Text] [Related]
11. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer. McCabe MT; Low JA; Daignault S; Imperiale MJ; Wojno KJ; Day ML Cancer Res; 2006 Jan; 66(1):385-92. PubMed ID: 16397253 [TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer. Mutze K; Langer R; Schumacher F; Becker K; Ott K; Novotny A; Hapfelmeier A; Höfler H; Keller G Eur J Cancer; 2011 Aug; 47(12):1817-25. PubMed ID: 21458988 [TBL] [Abstract][Full Text] [Related]
14. Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons. Reu FJ; Leaman DW; Maitra RR; Bae SI; Cherkassky L; Fox MW; Rempinski DR; Beaulieu N; MacLeod AR; Borden EC Cancer Res; 2006 Mar; 66(5):2785-93. PubMed ID: 16510600 [TBL] [Abstract][Full Text] [Related]
15. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells. Kassis ES; Zhao M; Hong JA; Chen GA; Nguyen DM; Schrump DS J Thorac Cardiovasc Surg; 2006 Feb; 131(2):298-306. PubMed ID: 16434257 [TBL] [Abstract][Full Text] [Related]
16. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Leu YW; Rahmatpanah F; Shi H; Wei SH; Liu JC; Yan PS; Huang TH Cancer Res; 2003 Oct; 63(19):6110-5. PubMed ID: 14559786 [TBL] [Abstract][Full Text] [Related]
17. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Gius D; Cui H; Bradbury CM; Cook J; Smart DK; Zhao S; Young L; Brandenburg SA; Hu Y; Bisht KS; Ho AS; Mattson D; Sun L; Munson PJ; Chuang EY; Mitchell JB; Feinberg AP Cancer Cell; 2004 Oct; 6(4):361-71. PubMed ID: 15488759 [TBL] [Abstract][Full Text] [Related]
18. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling. Shin H; Kim JH; Lee YS; Lee YC Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241 [TBL] [Abstract][Full Text] [Related]
19. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells. Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942 [TBL] [Abstract][Full Text] [Related]
20. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]